Further in vitro and in vivo investigations are warranted to confirm the potential anti-inflammatory role and the novel mechanism of action mediated by CB2 stimulation in containing and managing the impaired inflammatory state in IBD patients and its related side consequences. This evidence concerns the gene CNR2 and inflammatory bowel disease.